BlackRock Japan’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$26K Sell
2,662
-100
-4% -$1.09K ﹤0.01% 1080
2016
Q3
$33K Hold
2,762
– – ﹤0.01% 1036
2016
Q2
$24K Hold
2,762
– – ﹤0.01% 1134
2016
Q1
$26K Buy
2,762
+224
+9% +$2.11K ﹤0.01% 1149
2015
Q4
$44K Sell
2,538
-232
-8% -$3.7K ﹤0.01% 1054
2015
Q3
$37K Buy
2,770
+1,630
+143% +$32.7K ﹤0.01% 1021
2015
Q2
$26K Buy
1,140
+787
+223% +$13.8K ﹤0.01% 1159
2015
Q1
$5K Buy
+353
New +$5.09K ﹤0.01% 1274
2014
Q4
– Sell
-694
Closed -$6K – 1338
2014
Q3
$6K Buy
+694
New +$6.61K ﹤0.01% 1229
2014
Q2
– Sell
-1,562
Closed -$20K – 1331
2014
Q1
$20K Buy
+1,562
New +$23.2K ﹤0.01% 1275

Other funds holding HALO

BlackRock Japan's HALO Position: Q4 2016 in Review

BlackRock Japan reduced its Halozyme (HALO) stake by 3.6% in Q4 2016, selling an estimated $1.09K and leaving 2,662 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #1080.

BlackRock Japan first reported a position in HALO in Q1 2014 and has held it in 10 quarters since. The position peaked at $44K in Q4 2015. 168 funds tracked by Wall St. Rank hold HALO as of Q4 2016.

  • BlackRock Japan held 2,662 shares of Halozyme worth $26K as of Q4 2016.
  • BlackRock Japan sold 100 Halozyme shares in Q4 2016, an estimated $1.09K.
  • Halozyme made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1080 holding.
  • BlackRock Japan first reported a position in Halozyme in Q1 2014 and has held it in 10 quarters since.
  • BlackRock Japan's Halozyme position peaked at $44K in Q4 2015.
  • 168 funds tracked by Wall St. Rank held Halozyme as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.